PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1536.00 - 1565.00
1090.00 - 1784.00
46.2K / 155.6K (Avg.)
23.48 | 66.41
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
33.01%
Positive revenue growth while 6617.T is negative. John Neff might see a notable competitive edge here.
2.27%
Positive gross profit growth while 6617.T is negative. John Neff would see a clear operational edge over the competitor.
3437.74%
Positive EBIT growth while 6617.T is negative. John Neff might see a substantial edge in operational management.
-90.62%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
1636.83%
Positive net income growth while 6617.T is negative. John Neff might see a big relative performance advantage.
1636.88%
Positive EPS growth while 6617.T is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
1636.88%
Positive diluted EPS growth while 6617.T is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-0.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-93.78%
Negative 10Y revenue/share CAGR while 6617.T stands at 19.90%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
-37.77%
Negative 5Y CAGR while 6617.T stands at 19.90%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-30.47%
Negative 3Y CAGR while 6617.T stands at 2.03%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
115.89%
Net income/share CAGR above 1.5x 6617.T's 28.78% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
197.59%
5Y net income/share CAGR above 1.5x 6617.T's 28.78%. David Dodd would confirm if the firm’s strategy is more effective in generating mid-term profits.
355.48%
3Y net income/share CAGR above 1.5x 6617.T's 28.70%. David Dodd would confirm the company’s short-term strategies outmatch the competitor significantly.
No Data
No Data available this quarter, please select a different quarter.
184.50%
5Y equity/share CAGR above 1.5x 6617.T's 1.37%. David Dodd might see stronger earnings retention or fewer asset impairments fueling growth.
35.65%
3Y equity/share CAGR above 1.5x 6617.T's 4.49%. David Dodd verifies the company’s short-term capital management far exceeds the competitor’s pace.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
76.26%
Our AR growth while 6617.T is cutting. John Neff questions if the competitor outperforms in collections or if we’re pushing credit to maintain sales.
159.90%
Inventory growth well above 6617.T's 3.93%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
92.27%
Positive asset growth while 6617.T is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
13.38%
Positive BV/share change while 6617.T is negative. John Neff sees a clear edge over a competitor losing equity.
331.15%
Debt growth far above 6617.T's 4.57%. Michael Burry fears the firm is taking on undue leverage vs. the competitor.
-100.00%
Our R&D shrinks while 6617.T invests at 0.00%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
99.74%
SG&A growth well above 6617.T's 8.80%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.